Silencing of PD-L1 significantly suppressed inflammatory pathways upregulated by IFNγ, suggesting that targeting PD-L1 could enhance tumor suppression in ccRCC. The gene discussed is CD274; the disease is nonpapillary renal cell carcinoma.